{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:27:26Z","timestamp":1790432846938,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7594","license":[{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,3,17]]},"DOI":"10.1038\/nature17188","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T17:35:08Z","timestamp":1457458508000},"page":"335-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":327,"title":["Crystal structures of the M1 and M4 muscarinic acetylcholine receptors"],"prefix":"10.1038","volume":"531","author":[{"given":"David M.","family":"Thal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingfa","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vindhya","family":"Nawaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian C.","family":"Felder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Bures","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William I.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Bachhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong Sun","family":"Kobilka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Kobilka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"BFnature17188_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrd2379","volume":"6","author":"J Wess","year":"2007","unstructured":"Wess, J., Eglen, R. M. & Gautam, D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nature Rev. Drug Discov. 6, 721\u2013733 (2007)","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature17188_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.conb.2006.09.002","volume":"16","author":"ME Hasselmo","year":"2006","unstructured":"Hasselmo, M. E. The role of acetylcholine in learning and memory. Curr. Opin. Neurobiol. 16, 710\u2013715 (2006)","journal-title":"Curr. Opin. Neurobiol."},{"key":"BFnature17188_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1385\/JMN:30:1:133","volume":"30","author":"ME Hasselmo","year":"2006","unstructured":"Hasselmo, M. E. & Giocomo, L. M. Cholinergic modulation of cortical function. J. Mol. Neurosci. 30, 133\u2013135 (2006)","journal-title":"J. Mol. Neurosci."},{"key":"BFnature17188_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrd4295","volume":"13","author":"AC Kruse","year":"2014","unstructured":"Kruse, A. C. et al. Muscarinic acetylcholine receptors: novel opportunities for drug development. Nature Rev. Drug Discov. 13, 549\u2013560 (2014)","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature17188_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coph.2014.02.006","volume":"16","author":"AC Kruse","year":"2014","unstructured":"Kruse, A. C., Hu, J., Kobilka, B. K. & Wess, J. Muscarinic acetylcholine receptor X-ray structures: potential implications for drug development. Curr. Opin. Pharmacol. 16, 24\u201330 (2014)","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnature17188_CR6","first-page":"413","volume":"14","author":"DJ Foster","year":"2012","unstructured":"Foster, D. J., Jones, C. K. & Conn, P. J. Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling. Discov. Med. 14, 413\u2013420 (2012)","journal-title":"Discov. Med."},{"key":"BFnature17188_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","volume":"165","author":"A Shekhar","year":"2008","unstructured":"Shekhar, A. et al. Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. Am. J. Psychiatry 165, 1033\u20131039 (2008)","journal-title":"Am. J. Psychiatry"},{"key":"BFnature17188_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","volume":"54","author":"NC Bodick","year":"1997","unstructured":"Bodick, N. C. et al. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch. Neurol. 54, 465\u2013473 (1997)","journal-title":"Arch. Neurol."},{"key":"BFnature17188_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2008.12.044","volume":"605","author":"JN Heinrich","year":"2009","unstructured":"Heinrich, J. N. et al. Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists. Eur. J. Pharmacol. 605, 53\u201356 (2009)","journal-title":"Eur. J. Pharmacol."},{"key":"BFnature17188_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd2760","volume":"8","author":"PJ Conn","year":"2009","unstructured":"Conn, P. J., Christopoulos, A. & Lindsley, C. W. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nature Rev. Drug Discov. 8, 41\u201354 (2009)","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature17188_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1039\/c002938f","volume":"6","author":"GJ Digby","year":"2010","unstructured":"Digby, G. J., Shirey, J. K. & Conn, P. J. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Mol. Biosyst. 6, 1345\u20131354 (2010)","journal-title":"Mol. Biosyst."},{"key":"BFnature17188_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuropharm.2010.07.010","volume":"60","author":"P Keov","year":"2011","unstructured":"Keov, P., Sexton, P. M. & Christopoulos, A. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. Neuropharmacology 60, 24\u201335 (2011)","journal-title":"Neuropharmacology"},{"key":"BFnature17188_CR13","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/j.1476-5381.2010.01184.x","volume":"162","author":"S Suratman","year":"2011","unstructured":"Suratman, S. et al. Impact of species variability and \u2018probe-dependence\u2019 on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor. Br. J. Pharmacol. 162, 1659\u20131670 (2011)","journal-title":"Br. J. Pharmacol."},{"key":"BFnature17188_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/npp.2009.194","volume":"35","author":"K Leach","year":"2010","unstructured":"Leach, K. et al. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties. Neuropsychopharmacology 35, 855\u2013869 (2010)","journal-title":"Neuropsychopharmacology"},{"key":"BFnature17188_CR15","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1073\/pnas.0800567105","volume":"105","author":"WY Chan","year":"2008","unstructured":"Chan, W. Y. et al. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia. Proc. Natl Acad. Sci. USA 105, 10978\u201310983 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17188_CR16","doi-asserted-by":"publisher","first-page":"14271","DOI":"10.1523\/JNEUROSCI.3930-09.2009","volume":"29","author":"JK Shirey","year":"2009","unstructured":"Shirey, J. K. et al. A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning. J. Neurosci. 29, 14271\u201314286 (2009)","journal-title":"J. Neurosci."},{"key":"BFnature17188_CR17","doi-asserted-by":"publisher","first-page":"15950","DOI":"10.1073\/pnas.0900903106","volume":"106","author":"L Ma","year":"2009","unstructured":"Ma, L. et al. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. Proc. Natl Acad. Sci. USA 106, 15950\u201315955 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17188_CR18","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1074\/jbc.M113.539080","volume":"289","author":"A Abdul-Ridha","year":"2014","unstructured":"Abdul-Ridha, A. et al. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor. J. Biol. Chem. 289, 6067\u20136079 (2014)","journal-title":"J. Biol. Chem."},{"key":"BFnature17188_CR19","doi-asserted-by":"publisher","first-page":"33701","DOI":"10.1074\/jbc.M114.604967","volume":"289","author":"A Abdul-Ridha","year":"2014","unstructured":"Abdul-Ridha, A. et al. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor. J. Biol. Chem. 289, 33701\u201333711 (2014)","journal-title":"J. Biol. Chem."},{"key":"BFnature17188_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1124\/mol.111.070938","volume":"79","author":"K Leach","year":"2011","unstructured":"Leach, K., Davey, A. E., Felder, C. C., Sexton, P. M. & Christopoulos, A. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor. Mol. Pharmacol. 79, 855\u2013865 (2011)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR21","doi-asserted-by":"publisher","first-page":"19012","DOI":"10.1074\/jbc.M110.125096","volume":"285","author":"V Nawaratne","year":"2010","unstructured":"Nawaratne, V., Leach, K., Felder, C. C., Sexton, P. M. & Christopoulos, A. Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms. J. Biol. Chem. 285, 19012\u201319021 (2010)","journal-title":"J. Biol. Chem."},{"key":"BFnature17188_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature10867","volume":"482","author":"AC Kruse","year":"2012","unstructured":"Kruse, A. C. et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482, 552\u2013556 (2012)","journal-title":"Nature"},{"key":"BFnature17188_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10753","volume":"482","author":"K Haga","year":"2012","unstructured":"Haga, K. et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482, 547\u2013551 (2012)","journal-title":"Nature"},{"key":"BFnature17188_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nprot.2009.31","volume":"4","author":"M Caffrey","year":"2009","unstructured":"Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706\u2013731 (2009)","journal-title":"Nature Protocols"},{"key":"BFnature17188_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.str.2012.04.010","volume":"20","author":"E Chun","year":"2012","unstructured":"Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967\u2013976 (2012)","journal-title":"Structure"},{"key":"BFnature17188_CR26","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.str.2014.08.022","volume":"22","author":"TS Thorsen","year":"2014","unstructured":"Thorsen, T. S., Matt, R., Weis, W. I. & Kobilka, B. K. Modified T4 lysozyme fusion proteins facilitate G protein-coupled receptor crystallogenesis. Structure 22, 1657\u20131664 (2014)","journal-title":"Structure"},{"key":"BFnature17188_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S","volume":"37","author":"AM van Rhee","year":"1996","unstructured":"van Rhee, A. M. & Jacobson, K. A. Molecular architecture of G protein-coupled receptors. Drug Dev. Res. 37, 1\u201338 (1996)","journal-title":"Drug Dev. Res."},{"key":"BFnature17188_CR28","doi-asserted-by":"publisher","first-page":"34098","DOI":"10.1074\/jbc.M104217200","volume":"276","author":"Z-L Lu","year":"2001","unstructured":"Lu, Z.-L., Saldanha, J. W. & Hulme, E. C. Transmembrane domains 4 and 7 of the M1 muscarinic acetylcholine receptor are critical for ligand binding and the receptor activation switch. J. Biol. Chem. 276, 34098\u201334104 (2001)","journal-title":"J. Biol. Chem."},{"key":"BFnature17188_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0031-6997(24)01362-0","volume":"50","author":"MP Caulfield","year":"1998","unstructured":"Caulfield, M. P. & Birdsall, N. J. M. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50, 279\u2013290 (1998)","journal-title":"Pharmacol. Rev."},{"key":"BFnature17188_CR30","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1124\/mol.107.038265","volume":"72","author":"JA Goodwin","year":"2007","unstructured":"Goodwin, J. A., Hulme, E. C., Langmead, C. J. & Tehan, B. G. Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands. Mol. Pharmacol. 72, 1484\u20131496 (2007)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/157015907781695946","volume":"5","author":"KJ Gregory","year":"2007","unstructured":"Gregory, K. J., Sexton, P. M. & Christopoulos, A. Allosteric modulation of muscarinic acetylcholine receptors. Curr. Neuropharmacol. 5, 157\u2013167 (2007)","journal-title":"Curr. Neuropharmacol."},{"key":"BFnature17188_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0026-895X(25)14327-7","volume":"23","author":"JM Stockton","year":"1983","unstructured":"Stockton, J. M., Birdsall, N. J., Burgen, A. S. & Hulme, E. C. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23, 551\u2013557 (1983)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1124\/mol.56.6.1245","volume":"56","author":"AL Gnagey","year":"1999","unstructured":"Gnagey, A. L., Seidenberg, M. & Ellis, J. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol. Pharmacol. 56, 1245\u20131253 (1999)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR34","doi-asserted-by":"publisher","first-page":"8746","DOI":"10.1021\/jm401219y","volume":"56","author":"CS Tautermann","year":"2013","unstructured":"Tautermann, C. S. et al. Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor. J. Med. Chem. 56, 8746\u20138756 (2013)","journal-title":"J. Med. Chem."},{"key":"BFnature17188_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12735","volume":"504","author":"AC Kruse","year":"2013","unstructured":"Kruse, A. C. et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504, 101\u2013106 (2013)","journal-title":"Nature"},{"key":"BFnature17188_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.tips.2008.12.002","volume":"30","author":"PJ Conn","year":"2009","unstructured":"Conn, P. J., Jones, C. K. & Lindsley, C. W. Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol. Sci. 30, 148\u2013155 (2009)","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnature17188_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1124\/mol.114.091785","volume":"86","author":"DA Schober","year":"2014","unstructured":"Schober, D. A., Croy, C. H., Xiao, H., Christopoulos, A. & Felder, C. C. Development of a radioligand, [3H]LY2119620, to probe the human M2 and M4 muscarinic receptor allosteric binding sites. Mol. Pharmacol. 86, 116\u2013123 (2014)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1124\/mol.114.091751","volume":"86","author":"CH Croy","year":"2014","unstructured":"Croy, C. H. et al. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M2 and M4 receptors. Mol. Pharmacol. 86, 106\u2013115 (2014)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fendo.2014.00068","volume":"5","author":"E Khoury","year":"2014","unstructured":"Khoury, E., Cl\u00e9ment, S. & Laporte, S. A. Allosteric and biased g protein-coupled receptor signaling regulation: potentials for new therapeutics. Front. Endocrinol. 5, 68 (2014)","journal-title":"Front. Endocrinol."},{"key":"BFnature17188_CR40","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1074\/jbc.M610394200","volume":"282","author":"M Scarselli","year":"2007","unstructured":"Scarselli, M., Li, B., Kim, S. K. & Wess, J. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. J. Biol. Chem. 282, 7385\u20137396 (2007)","journal-title":"J. Biol. Chem."},{"key":"BFnature17188_CR41","doi-asserted-by":"publisher","first-page":"25677","DOI":"10.1074\/jbc.M702311200","volume":"282","author":"VA Avlani","year":"2007","unstructured":"Avlani, V. A. et al. Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligands. J. Biol. Chem. 282, 25677\u201325686 (2007)","journal-title":"J. Biol. Chem."},{"key":"BFnature17188_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.286.5438.295","volume":"286","author":"SW Lockless","year":"1999","unstructured":"Lockless, S. W. & Ranganathan, R. Evolutionarily conserved pathways of energetic connectivity in protein families. Science 286, 295\u2013299 (1999)","journal-title":"Science"},{"key":"BFnature17188_CR43","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665\u2013W667 (2004)","journal-title":"Nucleic Acids Res."},{"key":"BFnature17188_CR44","doi-asserted-by":"publisher","first-page":"W522","DOI":"10.1093\/nar\/gkm276","volume":"35","author":"TJ Dolinsky","year":"2007","unstructured":"Dolinsky, T. J. et al. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 35, W522\u2013W525 (2007)","journal-title":"Nucleic Acids Res."},{"key":"BFnature17188_CR45","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98, 10037\u201310041 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17188_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"WXDS Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D 66, 125\u2013132 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature17188_CR47","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007)","journal-title":"J. Appl. Crystallogr."},{"key":"BFnature17188_CR48","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1107\/S0907444904019079","volume":"60","author":"P Skub\u00e1k","year":"2004","unstructured":"Skub\u00e1k, P., Murshudov, G. N. & Pannu, N. S. Direct incorporation of experimental phase information in model refinement. Acta Crystallogr. D 60, 2196\u20132201 (2004)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature17188_CR49","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature17188_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature17188_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12\u201321 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature17188_CR52","unstructured":"Schrodinger, L. The PyMOL Molecular Graphics System, version 1.7.0.3 (2010)"},{"key":"BFnature17188_CR53","unstructured":"Schr\u00f6dinger release 2014-2: Maestro, version 9.7 (2014)"},{"issue":"Suppl. 1","key":"BFnature17188_CR54","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","volume":"30","author":"N Guex","year":"2009","unstructured":"Guex, N., Peitsch, M. C. & Schwede, T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 30 (Suppl. 1), S162\u2013S173 (2009)","journal-title":"Electrophoresis"},{"key":"BFnature17188_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","volume":"22","author":"K Arnold","year":"2006","unstructured":"Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195\u2013201 (2006)","journal-title":"Bioinformatics"},{"key":"BFnature17188_CR56","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier, A., Zoete, V. & Michielin, O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 39, W270\u2013W277 (2011)","journal-title":"Nucleic Acids Res."},{"key":"BFnature17188_CR57","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1124\/mol.108.049353","volume":"74","author":"V Nawaratne","year":"2008","unstructured":"Nawaratne, V. et al. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug). Mol. Pharmacol. 74, 1119\u20131131 (2008)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR58","doi-asserted-by":"crossref","unstructured":"Motulsky, H. & Christopoulos, A. Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting (Oxford Univ. Press, 2004)","DOI":"10.1093\/oso\/9780195171792.001.0001"},{"key":"BFnature17188_CR59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0026-895X(25)13145-3","volume":"33","author":"FJ Ehlert","year":"1988","unstructured":"Ehlert, F. J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33, 187\u2013194 (1988)","journal-title":"Mol. Pharmacol."},{"key":"BFnature17188_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ijch.201200096","volume":"53","author":"G Celniker","year":"2013","unstructured":"Celniker, G. et al. ConSurf: using evolutionary data to raise testable hypotheses about protein function. Isr. J. Chem. 53, 199\u2013206 (2013)","journal-title":"Isr. J. Chem."},{"key":"BFnature17188_CR61","doi-asserted-by":"publisher","first-page":"W529","DOI":"10.1093\/nar\/gkq399","volume":"38","author":"H Ashkenazy","year":"2010","unstructured":"Ashkenazy, H., Erez, E., Martz, E., Pupko, T. & Ben-Tal, N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 38, W529\u2013W533 (2010)","journal-title":"Nucleic Acids Res."},{"key":"BFnature17188_CR62","doi-asserted-by":"publisher","first-page":"W299","DOI":"10.1093\/nar\/gki370","volume":"33","author":"M Landau","year":"2005","unstructured":"Landau, M. et al. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res. 33, W299\u2013W302 (2005)","journal-title":"Nucleic Acids Res."},{"key":"BFnature17188_CR63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/bioinformatics\/19.1.163","volume":"19","author":"F Glaser","year":"2003","unstructured":"Glaser, F. et al. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19, 163\u2013164 (2003)","journal-title":"Bioinformatics"},{"key":"BFnature17188_CR64","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947\u20132948 (2007)","journal-title":"Bioinformatics"},{"key":"BFnature17188_CR65","unstructured":"Molecular Operating Environment (MOE) (Chemical Computing Group, 2015)"},{"key":"BFnature17188_CR66","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.1218231","volume":"336","author":"PA Karplus","year":"2012","unstructured":"Karplus, P. A. & Diederichs, K. Linking crystallographic model and data quality. Science 336, 1030\u20131033 (2012)","journal-title":"Science"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature17188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature17188","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature17188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T17:51:10Z","timestamp":1748800270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature17188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":66,"journal-issue":{"issue":"7594","published-print":{"date-parts":[[2016,3,17]]}},"alternative-id":["BFnature17188"],"URL":"https:\/\/doi.org\/10.1038\/nature17188","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]},"assertion":[{"value":"1 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C.F., M.G.B. and D.E. are employees of Eli Lilly.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}